EANS-Adhoc: Balda AG / Extraordinary General Meeting of Balda AG confirms the supervisory board members

08.02.2012
——————————————————————————–
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
adhoc with the aim of a Europe-wide distribution. The issuer is solely
responsible for the content of this announcement.
——————————————————————————–

08.02.2012

Bielefeld, 8 February 2012 – The extraordinary general meeting of Balda AG, Bad
Oeynhausen, today confirmed the members of the supervisory board in their
office. With a presence of 76.9 % of the share capital of the company, the
motions of the U.S.-American minority shareholder Octavian Special Master Fund,
L.P. to dismiss Dr. Michael Naschke, Mr. Yu-Sheng Kai and Mr. Chun-Chen Chen
received the required approval of more than 50 % of the votes cast in none of
the three cases. As a consequence, the election of the three candidates for the
supervisory board proposed by Octavian were no longer relevant.

Company profile of Balda AG
The Balda Group develops and produces complete plastic assemblies, electronic
products and products for the medical technology industry. Balda´s customers are
leading companies in the pharmaceutical, medical technology, consumer
electronics electronic communications and mobile phone markets. The Group is
internationally positioned with production sites in Germany and Malaysia. A
subsidiary in the USA operates in product design and development. Within the
scope of its shareholding in a leading touchscreen manufacturer in China, Balda
is participating in the dynamic development of the touchscreen displays market.

This ad-hoc announcement contains forward-looking statements, which are based on
the current expectations of Balda´s management. They therefore contain a range
of risks and uncertainties because they relate to future events and depend on
circumstances that will occur in the future, such as, for example, developments
in the mobile communications industry, changes in technology and the ability to
timely and successfully develop new products and various other factors. Balda
will neither revise these forward-looking statements nor correct them in the
event of any unexpected development, unless there is a legal obligation to do
so.

This ad-hoc announcement represents neither an offer to buy shares nor an
invitation to submit an offer to buy shares in the United States or any other
country. The shares in Balda AG (the ‘shares’) may not be offered or sold in the
United States or to or for the account of U.S. persons (as defined in Regulation
S of the U.S. Securities Act of 1933, in its current version (the ‘Securities
Act’)), unless they are registered or are exempt from registration under the
Securities Act. The shares have not been and will not be registered under the
Securities Act.

Further inquiry note:
Frank Elsner
Frank Elsner Kommunikation für Unternehmen GmbH
Tel.: +49 – 54 04 – 91 92 0
Fax: +49 – 54 04 – 91 92 29
Mail: office@elsner-kommunikation.de

issuer: Balda AG
Bergkirchener Str. 228
D-32549 Bad Oeynhausen
phone: +49 (0) 5734 9 22-0
FAX: +49 (0) 5734 922-2747
mail: info@balda.de
WWW: ¿U1http://www.balda.de¿U0
sector: Semiconductors & active components
ISIN: DE0005215107
indexes: CDAX, Prime All Share
stockmarkets: free trade: Berlin, München, Hamburg, Düsseldorf, Stuttgart,
regulated dealing/prime standard: Frankfurt
language: English